Drug Trial Radar · NCT07414524
VLA1553-403 Pregnancy Surveillance Study
Last checked: Nov 19, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
200
Planned (sponsor's estimate)
Start
Jun 11, 2026
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Valneva Austria GmbHIndustry
- Sponsor type
- Industry
- Collaborators
- Butantan Foundation; Coalition for Epidemic Preparedness Innovations
- First posted
- Feb 17, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This post-marketing, observational study evaluates pregnancy and infant outcomes up to 12 weeks after delivery among women who received the chikungunya vaccine (VLA1553) during pregnancy or within 30 days before their last menstrual period. A matched comparator cohort of pregnant women vaccinated with routine, pregnancy-recommended vaccines (not exposed to VLA1553) is included. No study procedures beyond routine care are performed.
Conditions
- Chikungunya Virus Infection
Interventions
Live-attenuated CHIKV vaccine VLA1553Biological
Non-interventional study: VLA1553 is used in the pilot vaccination strategy which will start along with this observational study.
Vaccine(s) approved for use during pregnancy by the MoHBiological
Vaccine(s) approved for use during pregnancy by the MoH
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency (n,%) of individuals with any outcome (pregnancy and infant health), as described in the protocol.Time frame: Study start through study completion, an average of 12 months
- Frequency (n,%) of specific outcomes (pregnancy and infant health), as described in the protocol.Time frame: Study start through study completion, an average of 12 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras
Belo Horizonte, Minas Gerais, Brazil
Fundação Faculdade Regional De Medicina De São José Do Rio Preto
São Pedro, São Paulo, Brazil
Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus
Laranjeiras, Sergipe, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.